Gaceta Médica, leading newspaper in health information, interviews Dra. Isabel Portero, CEO & Founder of BIOHOPE

“Closer to the personalization of renal transplant treatment.
First study to evaluate the functionality of the immunobiogram to predict the immunosuppressive response.”
> Read  More
2018-07-27T11:17:11+00:00July 26th, 2018|Clinical Development, Research|0 Comments